Questions About Cancer? 1-800-4-CANCER

Noteworthy Clinical Trials

Treatment Trials

  • The ALTTO Breast Cancer Trial
    (Updated: 10/03/2011) - A collection of material about the Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation, or ALTTO, study that will compare the targeted agents lapatinib and trastuzumab alone, in sequence, or in combination as adjuvant therapy for HER2-positive breast cancer.
  • The TAILORx Breast Cancer Trial
    (Posted: 05/23/2006, Reviewed: 10/22/2010) - A collection of material about the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, which will examine whether a molecular test can assign women with early-stage breast cancer to the most appropriate and effective treatment.

Testing and Screening Trials

  • National Lung Screening Trial (NLST)
    (Updated: 06/29/2011) - A collection of material about the National Lung Screening Trial (NLST), a research study sponsored by the National Cancer Institute that used low-dose helical CT scans or chest X-ray to screen men and women at risk for lung cancer.
  • Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    A large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from prostate, lung, colorectal, and ovarian cancer. In addition, there are numerous epidemiologic and ancillary studies going on that will answer other crucial questions about these cancers and these screening tests.